Last update :
19/11/2024
Immunosuppressant   Vedolizumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Entyvio Argentina, Belgium, France, Germany, Great Britain, Italy, Mexico, Peru, Romania, Spain, Switzerland, United States of America
References   injection   References : Vedolizumab  
Type Publication
2296 Manufacturer Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3711 Manufacturer Vedolizumab (Entyvio®) - Summary of Product Characteristics
Takeda 2015
4820 Journal Hendrickx T.C.J, Balcaen K.D.H, Baert M, Haustraete J, Lambrecht B.N.
Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags.
EJHP 2024

  Mentions Légales